EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II



From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II



Circulation 108(15): 1772-1778



Atherosclerotic cardiovascular disease results in >19 million deaths annually, and coronary heart disease accounts for the majority of this toll. Despite major advances in treatment of coronary heart disease patients, a large number of victims of the disease who are apparently healthy die suddenly without prior symptoms. Available screening and diagnostic methods are insufficient to identify the victims before the event occurs. The recognition of the role of the vulnerable plaque has opened new avenues of opportunity in the field of cardiovascular medicine. This consensus document concludes the following. (1) Rupture-prone plaques are not the only vulnerable plaques. All types of atherosclerotic plaques with high likelihood of thrombotic complications and rapid progression should be considered as vulnerable plaques. We propose a classification for clinical as well as pathological evaluation of vulnerable plaques. (2) Vulnerable plaques are not the only culprit factors for the development of acute coronary syndromes, myocardial infarction, and sudden cardiac death. Vulnerable blood (prone to thrombosis) and vulnerable myocardium (prone to fatal arrhythmia) play an important role in the outcome. Therefore, the term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future. (3) A quantitative method for cumulative risk assessment of vulnerable patients needs to be developed that may include variables based on plaque, blood, and myocardial vulnerability. In Part I of this consensus document, we cover the new definition of vulnerable plaque and its relationship with vulnerable patients. Part II of this consensus document will focus on vulnerable blood and vulnerable myocardium and provide an outline of overall risk assessment of vulnerable patients. Parts I and II are meant to provide a general consensus and overviews the new field of vulnerable patient. Recently developed assays (eg, C-reactive protein), imaging techniques (eg, CT and MRI), noninvasive electrophysiological tests (for vulnerable myocardium), and emerging catheters (to localize and characterize vulnerable plaque) in combination with future genomic and proteomic techniques will guide us in the search for vulnerable patients. It will also lead to the development and deployment of new therapies and ultimately to reduce the incidence of acute coronary syndromes and sudden cardiac death. We encourage healthcare policy makers to promote translational research for screening and treatment of vulnerable patients.

Accession: 010684078

Download citation: RISBibTeXText

PMID: 14557340

DOI: 10.1161/01.CIR.0000087481.55887.C9

Download PDF Full Text: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II



Related references

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108(14): 1664-1672, 2003

Vulnerable high-risk plaque (thin cap fibroatheroma): vulnerable patient/vulnerable blood. Anadolu Kardiyoloji Dergisi 6 Suppl 1: 8-12, 2006

Vulnerable plaque -- vulnerable vessel -- vulnerable patient. Plaques prone to rupture in atheroma/fibroatheroma. Herz 28(6): 483-487, 2003

Assessment of vulnerable plaque and vulnerable patient by optical coherence tomography. Nihon Rinsho. Japanese Journal of Clinical Medicine 69(2): 280-286, 2011

Vulnerable plaque versus vulnerable patient: emerging blood biomarkers for risk stratification. Endocrine, Metabolic & Immune Disorders Drug Targets 7(3): 195-201, 2007

Vulnerable plaque - vulnerable vessel - vulnerable patient Plaques prone to rupture, plaques at risk, unstable plaques. Herz 28(6): 483-487, September, 2003

Preventing future acute coronary events: is the target the so-called vulnerable plaque or the high-risk or vulnerable patient?. Current Opinion in Cardiology 24(5): 483-489, 2010

In search of the vulnerable patient or the vulnerable plaque: 18F-sodium fluoride positron emission tomography for cardiovascular risk stratification. Journal of Nuclear Cardiology, 2018

From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization. Trends in Cardiovascular Medicine 17(5): 162-171, 2007

Role of new imaging modalities in pursuit of the vulnerable plaque and the vulnerable patient. International Journal of Cardiology 250: 278-283, 2017

Coronary calcification identifies the vulnerable patient rather than the vulnerable Plaque. Atherosclerosis 229(1): 124-129, 2013

From the vulnerable plaque to the vulnerable patient: imaging and clinical implications. Academic Radiology 13(10): 1177-1179, 2006

Atherosclerotic coronary artery disease: usefulness of C-reactive protein for the identification of the vulnerable plaque and the vulnerable patient. Revista Espanola de Cardiologia 57(5): 375-378, 2004

Unstable atherosclerotic lesions tend to be disseminated in coronary arteries Shift from a vulnerable plaque to a vulnerable patient. European Heart Journal 23(Abstract Supplement): 368, August-September, 2002

Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?. Herz 28(6): 530-538, 2003